Delivery Order SPE2DB22D3501-SPE2DB26FTL52
Award Date 11/10/25
Potential Completion Date 11/12/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,306.32 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials. This firm fixed-price delivery order was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical procurement, which falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,838.12 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of June 3, 2025. This non-set-aside, firm fixed price delivery order represents a competitive award to the pharmaceutical distributor for medical supply provision supporting federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for CATHFLO Activase 2 MG vials, valued at $16,841.63 under a firm fixed price contract type. This delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $12,949.43 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials under a firm fixed-price contract. This non-set-aside award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a routine pharmaceutical procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $10,533.01 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cathflo Activase 2 mg vials, with an ultimate completion date of October 28, 2025. This non-set-aside contract represents a delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $7,372.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of August 7, 2025. This non-set-aside delivery order was competitively awarded on August 6, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,626.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award was issued on August 14, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,714.88 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, a thrombolytic medication used in medical settings. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 11, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used in medical settings. This firm fixed-price delivery order, valued at $5,429.76, is scheduled for completion by August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,262.40 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used to restore function to central venous catheters. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania,...